Therapeutic effect of hyperbaric oxygen in psoriasis vulgaris: Two case reports and a review of the literature

Journal of Medical Case Reports

Volumn 3, Issue , 2009, Pages

  Butler, Glenn ^a   Michaels, Julio Chvarri ^c   Al Waili, Noori ^a   Finkelstein, Michael ^a   Allen, Michael ^a   Petrillo, Richard ^a   Carrey, Zev ^a   Kolanuvada, Bangaruraju ^a   Lee, Bok Y ^a,b   Riera, Alfonso Gonzales ^c   Michaels, Cesar Chvarri ^c   Urteaga, Gary ^d  

^a Mount Vernon Hospital USA   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c Lima Center for Hyperbaric Medicine   (Peru)

^d Lima Center for Hyperbaric Medicine ^*  (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

LANOLIN ALCOHOL; OXYGEN;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CASE REPORT; DISEASE DURATION; DRUG EFFICACY; FOLLOW UP; HUMAN; HYPERBARIC OXYGEN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEDICAL LITERATURE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; REMISSION; TREATMENT OUTCOME;

EID: 72449149260     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-0003-0000007023     Document Type: Article

References (15)

1. Topical preparations for the treatment of psoriasis: a systematic review. J Mason AR Mason MJ Cork, Br J Dermatol 2002 146 351 364 11952534 10.1046/j.1365-2133.2000.04713.x (Pubitemid 34603806)
2. Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. DM Ashcroft AL Po HC Williams CE Griffiths, BMJ 2000 320 963 967 10753146 10.1136/bmj.320.7240.963
3. Tazarotene cream in the treatment of psoriasis: two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. GD Weinstein JY Koo GG Krueger MG Lebwohl NJ Lowe MA Menter, J Am Acad Dermatol 2003 48 760 767 12734506 10.1067/mjd.2003.103 (Pubitemid 36583288)
4. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. MG Lebwohl DL Breneman BS Goffe JR Grossman MR Ling J Milbauer, J Am Acad Dermatol 1998 39 590 596 9777766 10.1016/S0190-9622(98)70008-8 (Pubitemid 28465882)
5. A systematic review of adverse effects associated with topical treatments for psoriasis. CR Bruner SR Feldman M Ventrapragada AB Fleischer Jr, Dermatol Online J 2003 9 2 12639460
6. Chronic plaque psoriasis. L Naldi B Rzany, Clin Evid 2004 11 2140 2167 15652105
7. Biologic therapies for psoriasis. A systematic review. WH Boehncke J Prinz AB Gottlieb, J Rheumatol 2006 33 1447 1451 16724367
8. Effects of hyperbaric oxygen on inflammatory response to wound and trauma: possible mechanism of action. N Al-Waili G Butler, ScientificWorldJournal 2006 6 425 432 16604253 10.1100/tsw.2006.78
9. Hyperbaric oxygen and lymphoid system function: a review supporting possible intervention in tissue transplantation. N Al-Waili G Butler RL Petrillo Z Carrey RW Hamilton, Technol Health Care 2006 14 489 498 17148861
10. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. S Gottlieb P Gilleaudeau R Johnson L Estes TG Woodworth AB Gottlieb, Nat Med 1995 1 442 446 7585092 10.1038/nm0595-442
11. The immunologic basis for the treatment of psoriasis with new biologic agents. J Krueger, J Am Acad Dermatol 2002 46 1 23 11756941 10.1067/mjd.2002. 120568 (Pubitemid 34073472)
12. Hyperbaric oxygen reduces the progression and accelerates the regression of atherosclerosis in rabbits. B Kudchodkar J Wilson A Lacko L Dory, Arterioscler Thromb Vasc Biol 2000 20 1637 1643 10845883
13. Hyperbaric oxygenation in the comprehensive therapy of patients with rheumatoid arthritis (clinico-immunologic study) [in Russian]. V Lukich L Poliakova T Sotnikova D Belokrinitskii, Fiziol Zh 1991 37 55 60 1838726
14. Immune function in hyperbaric environments, diving, and decompression. I Brenner R Shephard P Shek, Undersea Hyperb Med 1999 26 27 39 10353182
15. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. M Benson M Minter B Osborne E Granowitz, Liver Transpl Surg 2003 134 57 62 12974755